How should I treat an adult patient with typhoid fever who has no known drug allergies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Typhoid Fever in Adults

Azithromycin 500 mg once daily for 7 days is the preferred first-line treatment for adults with typhoid fever, particularly given widespread fluoroquinolone resistance exceeding 70% in endemic regions. 1, 2

Immediate Diagnostic Steps Before Treatment

  • Obtain blood cultures immediately before starting antibiotics – blood cultures have 40-80% sensitivity and provide the highest diagnostic yield within the first week of symptom onset 1, 2, 3
  • Collect multiple large-volume specimens (20 mL each) to maximize sensitivity 3
  • If the patient is clinically unstable or shows signs of sepsis, start empiric treatment immediately after collecting cultures 1
  • Obtain baseline complete blood count (looking for lymphopenia and thrombocytopenia), comprehensive metabolic panel, and liver function tests 2, 3
  • Exclude malaria in all febrile travelers from tropical areas using both thick/thin smears and rapid diagnostic tests 2, 3

First-Line Antibiotic Treatment Algorithm

For Uncomplicated Cases (Oral Therapy)

Azithromycin is the preferred first-line agent:

  • Dose: 500 mg once daily for 7 days (some guidelines recommend 14 days to minimize relapse risk) 1, 2
  • Azithromycin demonstrates significantly lower clinical failure rates (OR 0.48) compared to fluoroquinolones 1
  • Hospital stays are approximately 1 day shorter with azithromycin versus fluoroquinolones 1
  • Relapse risk is dramatically lower (OR 0.09) compared to ceftriaxone, with relapse rates <3% 1, 2

For Severe Cases (IV Therapy Required)

Ceftriaxone is the first-line IV agent:

  • Dose: 1-2 g IV/IM once daily for 5-7 days (extend to 14 days to reduce relapse risk) 1, 2
  • Particularly important for patients from Asia where >70% of isolates are fluoroquinolone-resistant 1, 2
  • Relapse rates <8% when full courses are completed 1, 2

Critical Geographic Considerations

  • Never use ciprofloxacin empirically for cases from South or Southeast Asia – resistance approaches 96% in some regions 1, 2
  • Fluoroquinolone resistance exceeds 70% in isolates from South Asia 1, 2
  • Ciprofloxacin remains an alternative only if the patient traveled from sub-Saharan Africa AND nalidixic acid sensitivity is confirmed 1, 2
  • Pakistan has widespread ciprofloxacin-resistant and ceftriaxone-resistant typhoid 4

Expected Clinical Response and Monitoring

  • Expect fever clearance within 4-5 days of appropriate antibiotic therapy 1, 2
  • With susceptible organisms, fluoroquinolones achieve fastest fever clearance (often <4 days) 2
  • If fever persists beyond 48 hours in a clinically stable patient, reassess for alternative diagnoses or complications rather than empirically changing antibiotics 1
  • Persistent fever beyond 3 days despite empirical therapy should trigger investigation for breakthrough infections or complications 1

Treatment Duration to Prevent Relapse

  • Complete a full 14-day antibiotic course to minimize relapse risk, even if fever resolves earlier 1, 2
  • Relapse occurs in 10-15% of inadequately treated cases 1
  • Never discontinue antibiotics prematurely, even if fever resolves early 1

Complications to Monitor

  • Life-threatening complications (intestinal perforation, encephalopathy, gastrointestinal bleeding) occur in 10-15% of patients, typically in the second week of untreated illness 1, 2
  • Intestinal perforation typically occurs in patients with illness duration exceeding 2 weeks 1
  • Perform serial neurologic examinations regularly to detect encephalopathy 3
  • If perforation occurs, surgical intervention with simple excision and closure is required, with success rates up to 88.2% 1

Adjunctive Therapy

  • Consider corticosteroids in severe cases with toxic/delirious state or encephalopathy 2, 5
  • Supportive care with appropriate fluid and electrolyte management is essential 5

Common Pitfalls to Avoid

  • Never rely solely on the Widal test for diagnosis – it has poor specificity (68.44%) and very poor positive predictive value (5.7%) 1
  • Never use empiric ciprofloxacin for cases from Asia due to widespread resistance 1, 2
  • Never discontinue antibiotics prematurely, even if fever resolves early 1

Adverse Effects to Monitor

  • Common azithromycin adverse effects include gastrointestinal symptoms: nausea, vomiting, abdominal pain, and diarrhea 1
  • Monitor for potential drug interactions with azithromycin, particularly QT-prolonging medications 1

Infection Control and Public Health

  • Typhoid fever is a nationally notifiable disease – report immediately to local/state health departments with isolate submission for antimicrobial susceptibility testing 2, 3
  • Implement contact precautions with gloves and gowns, plus hand hygiene with soap and water (not alcohol alone) 3
  • Asymptomatic carriers in high-risk settings (healthcare, food service, childcare) should be treated according to local public health guidance 6

References

Guideline

Treatment of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Typhoid Fever Management and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Enteric (typhoid and paratyphoid) fever.

Lancet (London, England), 2025

Research

The management of typhoid fever.

Tropical doctor, 1976

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.